Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00350168
Status:
COMPLETED
Last Update Posted:
2016-11-18
First Post:
2006-07-07
Brief Title:
Efficacy Safety of Orally Administered ValsartanAmlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CVAA489A2403
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None